Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2001, p. 8592-8604, Vol. 21, No. 24
Howard Hughes Medical Institute and
Department of Immunology, University of Washington, Seattle,
Washington 98195
Received 16 July 2001/Returned for modification 28 August
2001/Accepted 18 September 2001
We have identified a novel LIM gene encoding the thymus LIM protein
(TLP), expressed specifically in the thymus in a subset of cortical
epithelial cells. TLP was identified as a gene product which is
upregulated in a thymus in which selection of T cells is occurring
(Rag
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8592-8604.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification and Characterization of Thymus LIM
Protein: Targeted Disruption Reduces Thymus Cellularity

/
OT-1) compared to its expression in a
thymus in which selection is blocked at the CD4+
CD8+ stage of T-cell development (Rag
/
Tap
/
OT-1). TLP has an apparent molecular mass of 23 kDa and exists as two isomers (TLP-A and TLP-B), which are generated by
alternative splicing of the message. The sequences of TLP-A and TLP-B
are identical except for the C-terminal 19 or 20 amino acids. Based on
protein sequence alignment, TLP is most closely related to the
cysteine-rich proteins, a subclass of the family of LIM-only proteins.
In both medullary and cortical thymic epithelial cell lines transduced
with TLP, the protein localizes to the cytoplasm but does not appear to
be strongly associated with actin. In immunohistochemical studies, TLP
seems to be localized in a subset of epithelial cells in the cortex and
is most abundant near the corticomedullary junction. We generated mice
with a targeted disruption of the Tlp locus. In the absence
of TLP, thymocyte development and thymus architecture appear to be
normal but thymocyte cellularity is reduced by approximately 30%, with
a proportional reduction in each subpopulation.
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute and Department of Immunology, University of
Washington, Seattle, WA 98195. Phone: (206) 685-3610. Fax: (206)
685-3612. E-mail: mbevan{at}u.washington.edu.
Present address: Immunex Corporation, Seattle, WA 98101.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|